← Leaderboards
Jacque L Duncan
University Of California San Francisco
$10,147,700
Attributed
$20,566,371
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,152,477 · 6
FDA$1,413,894 · 1
By mechanism
R01$11,307,785 · 2
U24$7,620,505 · 2
UG1$708,620 · 1
K08$683,728 · 1
R21$245,733 · 1
Top collaborators
- Joseph Carroll11 shared
- Austin Roorda10 shared
- Lawrence C Sincich9 shared
- Felice A Dunn1 shared
- Taras V Litvin1 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Lawrence C Sincich$7,342,371
- Nancy A McNamara$6,223,007
Others in their field
Top investigators on “Retina”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Krzysztof Palczewski · University Of California-Irvine$48,214,939
- Adam R Glassman · Jaeb Center For Health Research, Inc.$47,242,041
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- Adam Glassman · Jaeb Center For Health Research, Inc.$31,583,813
- Karen J Cruickshanks · University Of Wisconsin Madison$28,499,261
Research focus
RetinaPhotoreceptorsAffectConeVisionImageResolutionRetinal ConeAnimal ModelCellsStructureValidationMutationTechnologyRetinal DiseasesRetinitis PigmentosaVisualInnovationAdaptive Optics Scanning Laser OphthalmoscopyFovea CentralisIn VivoColorTranslationsRetinal Degeneration
Grant awards (33)
Development of a novel, noninvasive, sensitive measure of retinal dysfunction$245,733
R21 · FY2025 · EY
NAC Attack AOSLO Reading Center$163,188
UG1 · FY2025 · EY · contact PI
Expert curation of clinically significant variants in genes for early onset retinal degeneration$345,482
U24 · FY2024 · EY · contact PI
NAC Attack AOSLO Reading Center$162,127
UG1 · FY2024 · EY · contact PI
Advanced Technology to Study Visual Function on a Cellular Scale$1,060,564
R01 · FY2023 · EY
Expert curation of clinically significant variants in genes for early onset retinal degeneration$345,621
U24 · FY2023 · EY · contact PI
NAC Attack AOSLO Reading Center$203,063
UG1 · FY2023 · EY · contact PI
Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research$1,238,895
U24 · FY2022 · EY
Advanced Technology to Study Visual Function on a Cellular Scale$1,032,855
R01 · FY2022 · EY
Expert curation of clinically significant variants in genes for early onset retinal degeneration$361,134
U24 · FY2022 · EY · contact PI
NAC Attack AOSLO Reading Center$180,242
UG1 · FY2022 · EY · contact PI
Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research$86,234
U24 · FY2022 · EY
Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research$1,263,162
U24 · FY2021 · EY
Advanced Technology to Study Visual Function on a Cellular Scale$1,025,904
R01 · FY2021 · EY
Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research$231,815
U24 · FY2021 · EY
Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research$1,255,608
U24 · FY2020 · EY
Advanced Technology to Study Visual Function on a Cellular Scale$1,059,558
R01 · FY2020 · EY
Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research$1,211,170
U24 · FY2019 · EY
Advanced Technology to Study Visual Function on a Cellular Scale$1,098,171
R01 · FY2019 · EY
Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research$1,281,384
U24 · FY2018 · EY
Advanced Technology to Study Visual Function on a Cellular Scale$1,154,287
R01 · FY2018 · EY
Phase 2 Study of CNTF on Photoreceptor Structure in Retinitis Pigmentosa$296,187
R01 · FY2018 · FD · contact PI
Advanced Technology to Study Visual Function on a Cellular Scale$1,152,469
R01 · FY2017 · EY
Advanced Technology to Study Visual Function on a Cellular Scale$1,151,396
R01 · FY2016 · EY
Phase 2 Study of CNTF on Photoreceptor Structure in Retinitis Pigmentosa$339,167
R01 · FY2016 · FD · contact PI
Advanced Technology to Study Visual Function on a Cellular Scale$1,158,687
R01 · FY2015 · EY
Phase 2 Study of CNTF on Photoreceptor Structure in Retinitis Pigmentosa$388,841
R01 · FY2014 · FD · contact PI
Phase 2 Study of CNTF on Photoreceptor Structure in Retinitis Pigmentosa$389,699
R01 · FY2012 · FD · contact PI
THERAPY FOR DOMINANTLY INHERITED RETINAL DEGENERATIONS$146,845
K08 · FY2004 · EY
THERAPY FOR DOMINANTLY INHERITED RETINAL DEGENERATIONS$140,014
K08 · FY2003 · EY
THERAPY FOR DOMINANTLY INHERITED RETINAL DEGENERATIONS$137,799
K08 · FY2002 · EY
THERAPY FOR DOMINANTLY INHERITED RETINAL DEGENERATIONS$130,550
K08 · FY2001 · EY
THERAPY FOR DOMINANTLY INHERITED RETINAL DEGENERATIONS$128,520
K08 · FY2000 · EY